Biocept, Inc. (BIOCQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 3, 2025, 2:20 PM EDT
Biocept Market Cap
Biocept has a market cap or net worth of $263.00 as of September 4, 2025. Its market cap has decreased by -99.98% in one year.
Market Cap
263.00
Enterprise Value
n/a
Revenue
1.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 6, 2014, Biocept's market cap has decreased from 39.00M to 263.00, a decrease of -100.00%. That is a compound annual growth rate of -64.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 263.00 | -99.76% |
| Dec 29, 2023 | 110.29K | -98.78% |
| Dec 30, 2022 | 9.04M | -85.17% |
| Dec 31, 2021 | 60.97M | 2.50% |
| Dec 31, 2020 | 59.48M | 392.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |